【君实生物:特瑞普利单抗上市许可申请获得香港卫生署药物办公室受理】财联社4月24日电,君实生物公告,特瑞普利单抗上市许可申请获得香港卫生署药物办公室受理。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”